Physician profile
Robert Rhoades
NPI 1124347299
$9,292.41
in general payments reported to CMS, 2019-2025
20 companies · $2,504 in 2025
The $2,504 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,340 · 2022: $3,119 · 2023: $1,423 · 2024: $907 · 2025: $2,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,322 · Travel and Lodging: $1,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,321.52 |
| Travel and Lodging | $1,511.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,449.30 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Pacira Pharmaceuticals Incorporated | $1,786.37 | 2021-2023 | Iovera, Zilretta |
| Nevro Corp. | $1,440.72 | 2022-2024 | Senza |
| Stryker Corporation | $860.14 | 2025 | Augment Injectable |
| Spr Therapeutics, INC | $771.85 | 2022-2023 | Sprint Pns System |
| Abbvie INC. | $197.67 | 2025 | |
| Collegium Pharmaceutical, INC. | $196.75 | 2024-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.08 | 2023-2025 | Relistor |
| Mml US, INC. | $79.93 | 2023 | Reactiv8 |
| Vertex Pharmaceuticals Incorporated | $64.57 | 2025 | |
| Globus Medical, INC. | $44.40 | 2025 | Senza |
| Avanos Medical | $41.72 | 2023-2025 | Genvisc 850 Sodium Hyaluronate, Coolief* Cooled Radiofrequency |
| Pfizer INC. | $40.86 | 2025 | |
| Pacira Therapeutics, INC. | $39.06 | 2021 | |
| Grt US Holding, INC. | $32.99 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $32.70 | 2021 | |
| Amgen INC. | $17.18 | 2023 | Prolia, Evenity |
| Azurity Pharmaceuticals, INC. | $16.97 | 2025 | Horizant |
| Mallinckrodt Hospital Products INC. | $14.94 | 2025 | Acthar |
| Vertos Medical, INC. | $14.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rhoades listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.